90% of drug candidates fail — even after $20-80M in preclinical investment. Discover, design, & screen drug candidates faster with Rasayan. Built for scientists, API chemists, R&D, CDMOs.
This company has no org chart yet
This company has no teams yet
This company has no offices yet